News

PHEXCOM

Solution BY Communication

Call：+86 021-55807300

Position：Home > News >

California CDMO plots ambitious expansion in Geneva in biologics manufacturing play

Biologics have blossomed in recent years as a lucrative market for contract manufacturers, with drugmakers dropping big bucks in the field. A California CDMO is hoping to splash into the frayin a big
2020/10/21
Does Roche's Actemra work in COVID-19? New studies once again paint mixed picture

Roche’s arthritis drug Actemra was one of the earliest-identified COVID-19 treatment prospects. But the latest clinical studies have yielded mixed data—and seemingly contradictory results. A large ob
2020/10/20
Purdue reaches $8B settlement on federal opioid charges—but will it ever pay that amount?

After years in court over its role in the nation's opioid crisis, Purdue Pharma has signed a massive settlement to walk away from federal civil and criminal charges. But as the company wades throught
2020/10/20
GlaxoSmithKline offloads Polish plant with 700 workers to French CDMO Delpharm

With plans to take its consumer healthcare joint venture with Pfizer public in the next few years, GlaxoSmithKline has been in Marie Kondomode for some of its expansive global assets. After cutting a
2020/10/19
Merck CEO calls on private industry to 'stabilize society' amid racial injustice, economic downturn

In a tumultuous 2020, the COVID-19 pandemic and simmering racial protests have exposed gaps between the ideal America some of its citizens see and the real America on the ground. Few voices have capt
2020/10/19
Gilead's remdesivir has 'little or no effect' on COVID-19 recovery or mortality: WHO

Gilead Sciences’ antiviral remdesivir got an emergency authorization from the FDA to treat COVID-19 in May on the basis of a study showing the drug cut the recovery time for hospitalized patients by
2020/10/16
Roche hit by 'high-end' biosimilar attack as Ocrevus, Tecentriq bounce back from COVID-19 slowdown

Biosimilars historically haven't enjoyed the same success in the U.S. asin Europe. So industry watchers weren’t exactly sure how copycats to Roche’s big three cancer drugs—Avastin, Rituxan and Hercep
2020/10/15
DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy markets

With dozens of approvals expected in the coming years, the cell and gene therapy space has turned into a goldmine for contract manufacturers. But COVID-19 vaccines are also a potentially lucrative bu
2020/10/15
Thermo Fisher will add 2 new filling lines to global expansion plans with $130M Singapore plant

With global expansion plans underway, New Jersey contract manufacturer Thermo Fisher Scientific has signed some big checks in recent years to support its ambitious aims. Now, the company is set to bu
2020/10/14
Did oral COVID-19 vaccine maker Vaxart exaggerate Warp Speed role to benefit insiders? DOJ wants to find out

On Tuesday, California biotech Vaxart unveiled that it haddosedthe first subject in a phase 1 study of its oral tablet COVID-19 vaccine candidate. But the good news was clouded with investigations an
2020/10/14

Excipients